CureMetrix

The 2025 Society of Breast Imaging Symposium is just weeks away! CureMetrix will be on-site in Colorado Springs. Planning to attend? Send us a message if you'd like to connect during the event! Register today: https://lnkd.in/eUvXQ5zb #SBI2025 #Mammography #BreastImaging #WomensHealth

February is National Heart Awareness Month—a time to recognize the hard truths about heart health. Heart Disease is the leading cause of death for women of all ages in the United States. If you’re in your 40s, 30s, and even 20s, you can be at risk. You’re never too young to start protecting your heart. Learn more: https://lnkd.in/eidKqiTq At CureMetrix, we are committed to advancing AI research that enhances the value of screening programs worldwide. cmAngio, our FDA-cleared BAC detection technology, enables a mammogram to provide additional insights—identifying Breast Arterial Calcifications (BAC) alongside standard breast cancer screening. We are now focused on forthcoming research to further explore BAC association with CVD, and CKD, and improving women’s health. #AmericanHeartMonth, National Heart, Lung, and Blood Institute, American Heart Association *cmAngio? is FDA-cleared for BAC detection and localization. The device is not a diagnostic tool for cardiac or any other specific disease, nor does it predict the development of any disease.

Mark your calendars! The 5th annual My Breast Density Day is happening on February 19, 2025, kicking off the multi-week KNOW NOW Challenge hosted by My Density Matters. This global initiative empowers people to bridge awareness to action—helping individuals understand why breast density matters, where to find out their breast density, and what steps to take to ensure the best possible screening. Learn More: https://lnkd.in/gqazc75J #Mammography #BreastHealth #BreastCancer #BreastDensity

The future of healthcare is coming to Nashville! #ViVE2025 is happening February 16-19, bringing together health tech decision-makers to shape the future of the industry. Let’s connect and explore opportunities to drive innovation together. Reach out to schedule a meeting.

Did you know that it’s National Heart Failure Awareness Week? Nearly 7 million Americans over 20 have #heartfailure and the prevalence is expected to rise to 8.5 million by 2030.?How can we reverse this trend? Learn more at https://lnkd.in/g4Pm8rm4 At CureMetrix, we believe in making a difference. Our company is researching groundbreaking AI products that have the potential to reverse this trend and extend the impact and value of screening programs globally. #HFWeek2025 #AmericanHeartMonth Heart Failure Society of America, American Heart Association

Exciting news! We've entered into an agreement with Volpara Health, a Lunit Cancer Screening company, to expand access to cmAngio, our innovative AI solution for breast imaging. This will enable Volpara x Lunit customers, including over 3,500 facilities that use Volpara Health software for early detection, to gain access to our cmAngio software. We're excited to be partnering with the Volpara team. cmAngio turns a mammogram into a two-for-one exam—screening for breast cancer and at the same time detecting breast arterial calcifications. #WomensHealth #Mammography #AI #Radiology

Kudos to our customer, CureMetrix! ?? MDSAP certification is one of the biggest hurdles an ambitious medical device company can face - they've now unlocked multiple international markets in one big push ??? Congratulations to the entire team. cmAngio? is on its way to Canada AND Australia! ???? ???? #medicaldevice #lifescience

We are proud to announce that we have achieved MDSAP certification, reinforcing our commitment to safety, compliance, and accelerating the global expansion of AI-based #womenshealth solutions. As outlined by the U.S. Food & Drug Administration (FDA), the Medical Device Single Audit Program (MDSAP) allows a single regulatory audit of a medical device manufacturer’s quality management system (QMS) to satisfy the requirements of multiple regulatory agencies. This certification confirms that our medical device manufacturing processes comply with the regulatory requirements of Australia, Brazil, Canada, and the United States.

We will be attending the 2025 J.P. Morgan Healthcare Conference in San Francisco! This premier conference is the largest and most informative healthcare investment symposium in the industry, connecting global industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Interested in setting up a meeting? Send us a direct message! #JPM2025

Thank you to CARPL - Radiology AI Platform for hosting such an engaging Mammo AI Panel at #RSNA24! We were honored to join this incredible group of experts to discuss how AI is shaping the future of breast cancer detection and patient care.